Top

07-12-2024 | Breast Cancer | CORRESPONDENCE

Prevalence and impact of metabolic associated fatty liver disease in non‑metastatic breast cancer women at initial diagnosis: a cross‑sectional study in China: a letter to the editor

Authors: Shiyu Geng, Ying Zhu, Feiye Zhu

Published in: Clinical and Translational Oncology

Excerpt

Dear Editor, …

Jiang ZY, Liang XY, Hu L, Ran L, She RL, Ma CY, Feng JH, Song JY, Li ZX, Qu XQ, Peng BQ, Wu KN, Kong LQ. Prevalence and impact of metabolic associated fatty liver disease in non-metastatic breast cancer women at initial diagnosis: a cross-sectional study in China. Clin Transl Oncol. 2024. https://doi.org/10.1007/s12094-024-03665-4.CrossRefPubMed

Yuan C, Xu G, Zhan X, Xie M, Luo M, She L, Xue Y. Molybdenum target mammography-based prediction model for metastasis of axillary sentinel lymph node in early-stage breast cancer. Medicine (Baltimore). 2023;102(42): e35672. https://doi.org/10.1097/MD.0000000000035672.CrossRefPubMed

Ministry of Health of the People's Republic of China, Department of Disease Control. Guidelines for the Prevention and Control of Overweight and Obesity in Chinese Adults (Trial). Beijing: Ministry of Health; April 2003. Available from: https://www.bjcdc.org/data/upload/feipangfzzn.pdf

Lofterød T, Frydenberg H, Flote V, Eggen AE, McTiernan A, Mortensen ES, Akslen LA, Reitan JB, Wilsgaard T, Thune I. Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study. Breast Cancer Res Treat. 2020;182(1):215–27. https://doi.org/10.1007/s10549-020-05679-2.CrossRefPubMedPubMedCentral

Title: Prevalence and impact of metabolic associated fatty liver disease in non‑metastatic breast cancer women at initial diagnosis: a cross‑sectional study in China: a letter to the editor
Authors: Shiyu Geng
Ying Zhu
Feiye Zhu
Publication date: 07-12-2024
Publisher: Springer International Publishing
Keywords: Breast Cancer
Breast Cancer
Steatotic Liver Disease
Metabolic Dysfunction-Associated Steatotic Liver Disease
Published in: Clinical and Translational Oncology
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-024-03805-w

Elevate your expertise in aplastic anemia (Link opens in a new window)

Aplastic Anemia
Independent Medical Education

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases.

Supported by:

Pfizer

Developed by: Springer Healthcare IME

Learn more

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Targeted Therapy
On-demand webinar

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Podcast | Sexual health in older age

Springer Medicine

Prevalence and impact of metabolic associated fatty liver disease in non‑metastatic breast cancer women at initial diagnosis: a cross‑sectional study in China: a letter to the editor

Excerpt

Elevate your expertise in aplastic anemia (Link opens in a new window)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Podcast | Sexual health in older age

Springer Medicine

Excerpt

Please log in to get access to this content

Elevate your expertise in aplastic anemia (Link opens in a new window)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma